Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-22
2006-08-22
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S263000
Reexamination Certificate
active
07094782
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula I or II:and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
REFERENCES:
patent: 3910907 (1975-10-01), O'Brien et al.
patent: 3920652 (1975-11-01), Springer et al.
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4021556 (1977-05-01), Springer et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4892576 (1990-01-01), Kruger et al.
patent: 4990647 (1991-02-01), Himmler et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5089499 (1992-02-01), Barker et al.
patent: 5137887 (1992-08-01), Hashimoto et al.
patent: 5250534 (1993-10-01), Bell et al.
patent: 5397774 (1995-03-01), Nugent et al.
patent: 5428044 (1995-06-01), Bantick et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5464847 (1995-11-01), Courtemanche et al.
patent: 5484760 (1996-01-01), Bussler et al.
patent: 5486531 (1996-01-01), Schonafinger et al.
patent: 5723608 (1998-03-01), Yuan
patent: 6124289 (2000-09-01), He et al.
patent: 4243279 (1992-12-01), None
patent: 0 244 097 (1987-04-01), None
patent: 0 269 859 (1988-06-01), None
patent: 0 300 688 (1989-01-01), None
patent: 0 373 891 (1989-12-01), None
patent: 0 374 448 (1990-06-01), None
patent: 0 395 144 (1990-10-01), None
patent: 0 455 545 (1991-11-01), None
patent: 0 503 099 (1992-09-01), None
patent: 0 521 622 (1993-01-01), None
patent: 0 531 901 (1993-03-01), None
patent: 0 576 350 (1993-12-01), None
patent: 0 591 528 (1994-04-01), None
patent: 0 594 149 (1994-04-01), None
patent: 0 714 898 (1995-06-01), None
patent: 0 662 477 (1995-07-01), None
patent: 0 729 758 (1996-09-01), None
patent: 0 773 023 (1997-05-01), None
patent: 0 778 277 (1997-06-01), None
patent: 0 812 831 (1997-12-01), None
patent: 4211753 (1967-07-01), None
patent: 6157587 (1986-03-01), None
patent: 9535298 (1996-02-01), None
patent: WO92/10098 (1992-06-01), None
patent: WO92/20642 (1992-11-01), None
patent: WO93/07149 (1993-04-01), None
patent: WO94/09017 (1994-04-01), None
patent: WO94/13643 (1994-06-01), None
patent: WO94/13644 (1994-06-01), None
patent: WO94/13661 (1994-06-01), None
patent: WO94/13676 (1994-06-01), None
patent: WO94/13677 (1994-06-01), None
patent: WO95/11880 (1995-05-01), None
patent: WO95/32710 (1995-12-01), None
patent: WO95/33727 (1995-12-01), None
patent: WO95/33750 (1995-12-01), None
patent: WO95/34563 (1995-12-01), None
patent: WO96/19452 (1996-06-01), None
patent: WO96/23783 (1996-08-01), None
patent: WO96/35689 (1996-11-01), None
patent: WO96/39388 (1996-12-01), None
patent: WO96/39400 (1996-12-01), None
patent: WO97/00868 (1997-01-01), None
patent: WO97/14684 (1997-04-01), None
patent: WO97/29109 (1997-08-01), None
patent: WO97/29110 (1997-08-01), None
patent: WO 98/03510 (1998-01-01), None
patent: WO98/08821 (1998-03-01), None
patent: WO98/08846 (1998-03-01), None
patent: WO98/08847 (1998-03-01), None
Senga et al, Chemical Abstracts, vol. 96, Entry 181036s (1982).
O'Brien et al, Chemical Abstracts, vol. 84, Entry 44171n (1976).
Hungarian Novelty Search Report dated Oct. 2, 2002 (P0102187).
Arch. Pharma (Weinheim) 320, 487-491 (1987), Ibrahim et al.
Psychopharmacology (Britton, Lee, Koob) 94:306-311 (1988).
Life Sciences (Britton, Koob, Rivier, Vale) 31:363-367 (1982).
Bull. Soc. Chim, Belg. (Maquestiau, Taghret, Enyde) vol. 101/No. 2/1992.
Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide (DeSouza, Nemeroff) 221-224, 1990.
J. Med. Chem (Senga, et al.) 25:243-249 (1982).
Comprehensive Organic Synthesis (Trost, Fleming) 3:481-520, 1991.
Synapse (Battaglia, Webster, DeSouza) 1:572-581 (1987).
Science (Nemeroff, et al.) 226:1342 (1984).
Remington's Pharmaceutical Sciences (Gennardo, ed.) 17thed. P. 1418-1419, 1985.
Brain Research Reviews (Dunn, Berridge) 15:71-100 (1990).
Proc. Natl. Acad. Sci. (Rivier, Spiess, Vale) 80:4851-4855 (1983).
Recent Progress in Hormone Research (Vale, et al.) 39:245-271 (1983).
Journal of Neuroscience (DeSouza, et al.) Vo. 5, No. 12, P. 3189-3203 (1985).
Perspectives on Behavioral Medicine (Koob) 2:39-52 (1985).
Biol. Psychiatry (France, et al.) 23:86-88 (1988).
Hormones and Behavior (Berridge, Dunn) 21:393-401 (1987).
Hospital Practice (De Souza) p. 59-71 (1988).
Arch. Gen Psychiatry (Sapolsky) 46:1047-1051 (1989).
Psychopharmacology (Britton, et al.) 86:170-174 (1985).
Biol. Psychiatry (Arato, et al.) 25:355-359 (1989).
Regulatory Peptides (Berridge, Dunn) 16 83-93 (1986).
Neuropsychopharmacology (Grigoriadis, et al.) Vo. 2, No. 1, p. 53-60 (1989).
Psychopharmacology (Swerdlow, Geyer, Vale, Koob) 88:147-152 (1986).
Am. J. Psychiatry (Banki et al.) 144:873-877 (1987).
Arch. Gen. Psychiatry (Nemeroff, et al.) 45:577-579 (1988).
New Eng. J. Med. (Gold, et al.) vol. 314, No. 21, p. 1329-1335 (1986).
Life Sciences (Morley, et al.) 41:527-544 (1987).
Physiological Reviews (Blalock) Vo. 69, No. 1, p. 1-33 (1989).
Journal f. prakt. Chemie. (Joshi, Dubey) Band 321, Heft 2, p. 341-344 (1979).
Journal of Medicinal Chemistry (Springer et al.) vol. 19, No. 2, p. 291-296 (1976).
J. Heterocyclic Chem. (O'Brien et al.) 22:601-634 (1985).
J. Med. Chem (Senga, Novinson, Wilson) 24:610-613 (1981).
Science (Vale, et al.) 213:1394-1397 (1981).
Chemical Abstracts, vol. 67, No. 28, 1967, abstract #108663r, Takamizawa et al.
Chemical Abstracts, vol. 74, No. 28, 1971, abstract #22867t, Takamizawa et al.
Chemical abstracts, vol. 74, No. 28, 1971, abstract #22872r, Takamizawa et al.
Chemical abstracts, vol. 68, No. 28, 1968, abstract 114635v, Takamizawa et al.
Arvanitis Argyrios Georgios
Chorvat Robert
Gilligan Paul
He Liqi
Bristol--Myers Squibb Company
Makujina Shah R.
Truong Tamthom N.
Wilson James O.
Woodcock & Washburn LLP
LandOfFree
Azolo triazines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolo triazines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolo triazines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644634